Indeed, blockade of either ILT2/CD85j or membrane-bound HLA-G with the corresponding neutralizing mAbs increases NK cell cytotoxicity against CLL cells [149,178]. This evidence concerns the gene HLA-G and B-cell chronic lymphocytic leukemia.